Recherchiere Firmenbekanntmachungen und finanzielle Kennzahlen
EU-Förderung (12,7 Mio. €): Physiologisch verankerte Werkzeuge für realistische nanOmateriaL Gefahr aSsessment Hor01.01.2018 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Physiologisch verankerte Werkzeuge für realistische nanOmateriaL Gefahr aSsessment
Nanotechnology promises significant scientific, economic and societal benefits, but commercialization and growth are threatened by safety uncertainties. Classical hazard testing strategies to define the human and environmental health impact of engineered nanomaterials (ENM) commonly apply unrealistic acute, high-doses to models that do not reflect the in vivo environment. Furthermore, existing in vitro and in silico hazard detection methods are not accurately predictive. PATROLS addresses these limitations by establishing and standardizing the next generation of advanced safety assessment tools for improved prediction of the adverse effects caused by chronic ENM exposure in human and environmental systems. PATROLS will deliver: 1) physiologically representative multi-cellular in vitro 3D lung, gastrointestinal tract and liver models; 2) cross-species models integrating human and environmental safety testing; 3) innovative ecotoxicity bioassays in several organisms across a food chain; 4) robust in silico models for dosimetry, interspecies toxicity extrapolation and hazard prediction. ENM characterization under physiologically relevant experimental conditions will be integral to this realistic, exposure driven strategy. A systems biology approach will also be adopted to identify key events linked to adverse outcome pathways, informing mechanism-based endpoints associated with real-life ENM exposures. These objectives will be achieved by an international network of world-leading academic, governmental, industrial, SME, risk assessment agency and NGO partners. The innovative in vitro and in silico nanosafety testing tools developed by PATROLS will balance speed, cost and biological complexity, while reducing uncertainty via improved predictive power. The smart targeted testing approach will drive a paradigm shift in (eco)toxicology towards mechanism-based ENM hazard assessment to support policy development in human and environmental nanosafety regulatory frameworks.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| BASF SE | 684.843 € |
| Consiglio Nazionale Delle Ricerche | 441.845 € |
| DET Nationale Forskningscenter FOR Arbejdsmiljø | 758.366 € |
| Danmarks Tekniske Universitet | 821.238 € |
| EUROPEAN RESEARCH SERVICES GmbH | 311.250 € |
| 0,00 € | |
| Heriot-Watt University | 1.166.364 € |
| INSPHERO AG | 481.961 € |
| IUF - LEIBNIZ-INSTITUT für UMWELTMEDIZINISCHE FORSCHUNG GmbH | 597.253 € |
| Institute of Occupational Medicine | 370.816 € |
| 0,00 € | |
| MISVIK BIOLOGY Oy | 336.325 € |
| Nanotechnology Industries Association | 251.469 € |
| Qsar Lab sp. z o.o. | 353.194 € |
| 881.765 € | |
| Swansea University | 1.511.624 € |
| 590.886 € | |
| 863.390 € | |
| United Kingdom Research and Innovation | 88.656 € |
| Universita DI Pisa | 384.930 € |
| Universite Catholique de Louvain | 428.826 € |
| Universite de Namur ASBL | 538.713 € |
| Universiteit Leiden | 850.468 € |
| 0,00 € |
Quelle: https://cordis.europa.eu/project/id/760813
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.
Die Visualisierungen zu "BASF SE - EU-Förderung (12,7 Mio. €): Physiologisch verankerte Werkzeuge für realistische nanOmateriaL Gefahr aSsessment"
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
